Results 81 to 90 of about 609,040 (315)

A case of API2-MALT1-positive gastric MALT lymphoma with concomitant diffuse large B-cell lymphoma [PDF]

, 2017
2017-05API2-MALT1 translocation-positive gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) lymphoma is thought to transform to diffuse large B-cell lymphoma (DLBCL) rarely.
Toriyama, Kazuhiro, Fujita, Akashi, Hieda, Nobuhiro, Ishihara, Makoto, Niwa, Yasumasa, Hirayama, Takashi, Tanaka, Tsutomu, Shibuya, Hitoshi, Mizuno, Nobumasa, Hara, Kazuo, Suzuki, Hirotaka, Yamao, Kenji, Tajika, Masahiro, Yatabe, Yasushi, Kondo, Hisashi, Okuno, Nozomi, Yoshida, Tsukasa, Hijioka, Susumu, Imaoka, Hiroshi, Hirayama, Yutaka   +19 more
core   +1 more source

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica, 2022
Andrew P. Jallouk, Sushanth Gouni, Jason Westin, Lei Feng, Haleigh Mistry, Raphael E. Steiner, Jinsu James, Mansoor Noorani, Sandra Horowitz, Nahum Puebla-Osorio, Luis E. Fayad, Swaminathan P. Iyer, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta J. Nastoupil, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Yago Nieto, Paolo Strati   +20 more
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Malignant lymphomas (ML) and HIV/AIDS Infection in Tanzania. [PDF]

, 2008
\ud HIV infection is reported to be associated with some malignant lymphomas (ML) so called AIDS-related lymphomas (ARL), with an aggressive behavior and poor prognosis.
Mwakigonja Amos R, Mgaya, Edward M, Mwakigonja, Amos R, Kaaya Ephata E, Mgaya Edward M, Kaaya, Ephata E   +5 more
core   +1 more source

Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy

Cancer Immunology, Immunotherapy
Background Autologous hematopoietic cell transplantation (ASCT) is a reasonable consolidation therapy for eligible patients with chemosensitive relapsed central nervous system lymphoma (CNSL) who have achieved complete remission (CR) and maintained the ...
Fan Yang, Rui Liu, Zhonghua Fu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Haifeng Wu, Chen Chen, Xiaoyan Ke, Kai Hu   +10 more
doaj   +1 more source

[Composite lymphoma cosisting of mantle cell lymphoma and follicular lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
Herein, we report the case of a 56-year-old man with composite lymphoma (CL) comprised of mantle cell lymphoma (MCL) and follicular lymphoma (FL). Six months after developing a right brachial tumor, he was diagnosed as having grade 3 FL with normal-size mantle zone.
MATSUOKA, Akihito, TSUSHIMA, Tomoyuki, TANIBUCHI, Masaki, KATSUKI, Naomi, KUSHIDA, Yoshio, TAKATA, Katsuyoshi, TAOKA, Teruhisa   +6 more
openaire   +2 more sources

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma [PDF]

, 2008
Background Burkitt's lymphoma is an aggressive B-cell lymphoma characterized by typical morph 0 logical, immunophenotypic and molecular features. Gene expression profiling provided a molecular signature of Burkitt's lymphoma, but also demonstrated that a
Braziel, Rita M., Salaverria, Itziar, Gascoyne, Randy D., Rimsza, Lisa M., Chan, Wing C., Zettl, Andreas, Mueller-Hermelink, Hans Konrad, Lopez-Guillermo, Armando, Ott, German, Weisenburger, Dennis D., Delabie, Jan, Hartmann, Elena M., Rosenwald, Andreas, Boerma, Evert-Jan, Dave, Sandeep S., Wright, George W., Campo, Elias, Kluin, Philip M., Jaffe, Elaine S., Staudt, Louis M., Bea, Silvia   +20 more
core   +1 more source

PB2671: AN INVESTIGATION INTO THE PREFERENCES OF PATIENTS REGARDING THE USE OF TELEMEDICINE STEMMING FROM THE COVID-19 PANDEMIC.

HemaSphere, 2023
Steve Kalloger, Cherie Bates, Amanda Watson, Lorna Warwick   +3 more
doaj   +1 more source

Baseline immunonutritional status drives CAR T-cell efficacy, survival, and safety in R/R lymphoma: validation of a pre-lymphodepletion PNI threshold

Annals of Hematology
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment landscape for relapsed/refractory (R/R) lymphoma. However, heterogeneous responses and treatment-related toxicities remain significant challenges.
Na Zhang, Fan Yang, Rui Liu, Zhonghua Fu, Danyang Li, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Shilin Gan, Chen Chen, Xiaoyan Ke, Kai Hu   +12 more
doaj   +1 more source